Skip to main content
Premium Trial:

Request an Annual Quote

'Right Treatment, Right Time' in the State of the Union

During his State of the Union address last night, US President Barack Obama announced a new precision medicine initiative to "bring us closer to curing diseases like cancer and diabetes, and to give all of us access to the personalized information we need to keep ourselves and our families healthier."

This, he added, will usher in "a new era of medicine  —  one that delivers the right treatment at the right time."

The White House is defining precision medicine as an "approach to treating illnesses that takes into account a patient's individual genetic make-up as well as molecular subtypes of diseases to improve the chances of successful treatment."

While the Verge notes that the details of the initiative are unclear, it adds that one of the guests at the speech was Bill Elder. According to the White House blog, Elder has cystic fibrosis, but has been treated with a drug that targets the underlying cause of cystic fibrosis in some patients. He now, the blog adds, is expected to live a long life.

"With genetic testing cheaper than ever, there's been a glut of genetic information available to doctors, but medicine has been slow to develop treatments that make use of this new data," the Verge says. "If the new initiative leads to treatments, it could mean a new front in the war on common diseases like heart disease."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.